Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Jefferies Group reduced their FY2017 earnings estimates for Henry Schein in a research note issued to investors on Friday. Jefferies Group analyst B. Couillard now forecasts that the company will post earnings per share of $3.63 for the year, down from their prior forecast of $3.64. Jefferies Group has a “Hold” rating and a $89.00 price objective on the stock. Jefferies Group also issued estimates for Henry Schein’s Q4 2017 earnings at $0.98 EPS, Q3 2018 earnings at $0.98 EPS, Q4 2018 earnings at $1.03 EPS and FY2018 earnings at $3.95 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter last year, the company posted $0.82 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year.

WARNING: “Jefferies Group Research Analysts Cut Earnings Estimates for Henry Schein, Inc. (HSIC)” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/23/jefferies-group-research-analysts-cut-earnings-estimates-for-henry-schein-inc-hsic.html.

A number of other equities analysts have also weighed in on the company. Credit Suisse Group reissued a “hold” rating and issued a $87.50 target price on shares of Henry Schein in a research report on Tuesday, August 29th. Piper Jaffray Companies raised Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. UBS AG reissued a “buy” rating on shares of Henry Schein in a research report on Friday, September 15th. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a research report on Thursday, July 6th. Finally, Morgan Stanley initiated coverage on Henry Schein in a research report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 target price for the company. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $92.89.

Shares of Henry Schein (NASDAQ HSIC) opened at 84.53 on Monday. The stock has a market cap of $13.37 billion, a P/E ratio of 24.70 and a beta of 1.08. Henry Schein has a 12-month low of $73.11 and a 12-month high of $93.50. The company’s 50-day moving average is $82.46 and its 200-day moving average is $87.26.

Henry Schein declared that its board has authorized a stock buyback program on Monday, September 18th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to repurchase up to 6.3% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 1.19% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Eads & Heald Investment Counsel boosted its stake in Henry Schein by 0.5% in the 2nd quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock worth $274,000 after purchasing an additional 8 shares during the period. Intrust Bank NA boosted its stake in Henry Schein by 1.1% in the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock worth $223,000 after purchasing an additional 13 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Henry Schein by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock worth $1,079,000 after purchasing an additional 19 shares during the period. YorkBridge Wealth Partners LLC boosted its stake in Henry Schein by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares during the period. Finally, Sawtooth Solutions LLC boosted its stake in Henry Schein by 2.4% in the 2nd quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock worth $247,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 44.74% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.